Effects of multiple doses of montmorillonite, alone and in combination with activated charcoal, on the toxicokinetics of a single dose of digoxin in rats

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 117

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-26-8_007

تاریخ نمایه سازی: 3 تیر 1402

Abstract:

Objective(s): A narrow margin between the therapeutic and toxic doses of digoxin can result in an increased incidence of toxicity.  Since digoxin has an enterohepatic cycle, multiple oral doses of absorbents like montmorillonite may be useful in the treatment of digoxin toxicity.Materials and Methods: In this study, ۴ groups of ۶ rats received intraperitoneal digoxin (۱ mg/kg), and half an hour later, distilled water (DW) or oral adsorbents, including montmorillonite (۱ g/kg), activated charcoal (۱ g/kg) (AC) alone or in combination in the ratio of ۷۰:۳۰. Half of the mentioned doses were also gavaged at ۳ and ۵.۵ hr after digoxin injection. The serum level of digoxin, biochemical factors, and activity score were assessed during the experiment. Three control groups only received DW, montmorillonite, or AC.Results: All adsorbents were able to significantly decrease the serum level of digoxin compared to the digoxin+DW group (P<۰.۰۱). Only montmorillonite reversed the digoxin-induced hyperkalemia (P<۰.۰۵). Multiple dose administration of adsorbents also significantly reduced the digoxin area under the curve and half-life and increased digoxin clearance (P<۰.۰۵). However, there was no significant difference in the kinetic parameters between groups that received digoxin plus adsorbents.Conclusion: Multiple-dose of montmorillonite reversed digoxin toxicity and reduced serum digoxin levels by increasing the excretion and reducing the half-life. Montmorillonite has also corrected digoxin-induced hyperkalemia.  Based on the findings, a multiple-dose regimen of oral montmorillonite could be a suitable candidate for reducing the toxicity issue associated with drugs like digoxin that undergo some degree of enterohepatic circulation.

Authors

Fatemeh Heydarian

Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Mohamad Moshiri

Department of Clinical Toxicology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Ali Roohbakhsh

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Akaberi

Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Atoosa Haghighizadeh

Department of Pharmaceutical and Food Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Ameneh Ghadiri

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Negar Yeganeh Khorasani

Student Research Committee, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Leila Etemad

International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Palatnick W, Jelic T. Calcium channel blocker and beta blocker ...
  • Zyoud SeH, Waring WS, Al-Jabi SW, Sweileh WM. Bibliometric profile ...
  • Lip GY, Metcalfe MJ, Dunn FG. Diagnosis and treatment of ...
  • Hauptman PJ, Blume SW, Lewis EF, Ward S. Digoxin toxicity ...
  • Moshiri M, Imenshahidi M, Moallem S, Ghadirie A, Nyasmand A, ...
  • Mirhoseini Moosavi P, Astaraei AR, Moshiri M, Etemad L, Zeinali ...
  • Porubcan LS, Born GS, White JL, Hem SL. Interaction of ...
  • Pinto N, Halachmi N, Verjee Z, Woodland C, Klein J, ...
  • Patocka J, Nepovimova E, Wu W, Kuca K. Digoxin: Pharmacology ...
  • Frost C, Song Y, Yu Z, Wang J, Lee LS, ...
  • de Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake ...
  • Smith SW, Howland MA. Chapter A۱: Activated Charcoal. In: Nelson ...
  • Critchley JA, Critchley LA. Digoxin toxicit in chronic renal failure: ...
  • Wang X, Mondal S, Wang J, Tirucherai G, Zhang D, ...
  • Wang Z, Cui M, Tang L, Li W, Wei Y, ...
  • Ukaonu C, Hill DA, Christensen F. Hypokalemic myopathy in pregnancy ...
  • Lalonde RL, Deshpande R, Hamilton PP, McLean WM, Greenway DC. ...
  • Nielsen RB, Kahnt A, Dillen L, Wuyts K, Snoeys J, ...
  • Setime MA, Sesay S, Cainelli F, Vento S. A case ...
  • Yu DY, Li XL, Li WF. Effect of montmorillonite superfine ...
  • YuZ DY, XuX ZR, Yang G. In vitro, in vivo ...
  • Palmer SJ. Digoxin toxicity (۲۰۱۹). J Paramedic Practice ۲۰۱۹; ۱۱:۳۶۰-۳۶۰ ...
  • Bauman JL, Didomenico RJ, Galanter WL. Mechanisms, manifestations, and management ...
  • Flanagan RJ, Jones AL. Fab antibody fragments. Some applications in ...
  • Davey M. Calcium for hyperkalaemia in digoxin toxicity. Emerg Med ...
  • Severance Jr H, Holt T, Patrone NA, Chapman L. Profound ...
  • Hosseini Azad SA, Moshiri M, Roohbakhsh A, Shakeri A, Fatemi ...
  • نمایش کامل مراجع